Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Ecotoxicol Environ Saf ; 74(5): 1325-30, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21496923

RESUMO

This study examined the effect of benzyl butyl phthalate (BBP), a phthalate ester (PAE) and an endocrine disruptor, on water celery, Ipomoea aquatica Forsk., one of the most popular leaf vegetables in Taiwan. After 28 days of cultivation, treatment with 100 mgL⁻¹ BBP retarded plant growth and decreased biomass and number of mature leaves and caused the accumulation of proline in leaves of water celery, but the concentrations of chlorophyll a and b in the leaves remained constant. 2-D gel electrophoresis and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of the proteome of leaf tissue revealed five protein spots with up- and down-regulated expression. The predicted protein XP_001417439 was down-regulated, which explained inhibition of plant growth, and the proteina XP_001417040, calreticulin, GAI-like protein 1, and (-)-linalool synthase were up-regulated, which indicates interference with the cell cycle and protein synthesis, as well as dwarfism of water celery. BBP is a stressor on the growth of water celery, and proteome analysis revealed the up- and down-regulation of genes involved in plant growth with BBP treatment.


Assuntos
Ipomoea/efeitos dos fármacos , Ácidos Ftálicos/toxicidade , Proteínas de Plantas/metabolismo , Proteoma/metabolismo , Poluentes Químicos da Água/toxicidade , Calreticulina/metabolismo , Clorofila/metabolismo , Clorofila A , Regulação para Baixo , Disruptores Endócrinos/toxicidade , Hidroliases/metabolismo , Ipomoea/crescimento & desenvolvimento , Ipomoea/metabolismo , Folhas de Planta/efeitos dos fármacos , Folhas de Planta/crescimento & desenvolvimento , Proteínas de Plantas/genética , Proteoma/genética , Taiwan , Regulação para Cima
2.
Infect Immun ; 73(12): 7946-52, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16299286

RESUMO

Intrachamber challenge with Porphyromonas gingivalis strain 381 in a mouse subcutaneous chamber model results in a local infection that progresses to exfoliation of the chambers within 15 days. This study was designed to elucidate the contribution of host reactions to tissue destruction manifested by chamber exfoliation in animals infected with P. gingivalis. Chamber fluids showed increasing levels of prostaglandin E(2) with infection, and the levels of tumor necrosis factor (TNF) in chamber fluids peaked just before chamber exfoliation. Intraperitoneal injection of a TNF inhibitor, thalidomide (TH), reduced the number of exfoliated chambers, while indomethacin had no effect. Exogenous TNF in chambers without bacterial infection did not cause chamber exfoliation but induced neutrophil infiltration. In a dual-chamber model, two chambers were implanted in the same mouse. One chamber was infected with P. gingivalis, and 9 days later exogenous TNF was added to the other chamber. Altogether, 66.67% of uninfected chambers were exfoliated between day 11 and day 16, although no bacteria were recovered from uninfected chambers. TH treatment alleviated both infected and uninfected chamber exfoliation. In this study, tissue destruction caused by P. gingivalis 381 infection was due to the elevation of the TNF levels and not due to local bacterial activities. Our results further indicate that local infection by P. gingivalis 381, a nondisseminating strain, actually has systemic effects on the host pathological outcome.


Assuntos
Infecções por Bacteroidaceae/imunologia , Infecções por Bacteroidaceae/patologia , Porphyromonas gingivalis , Fator de Necrose Tumoral alfa/metabolismo , Animais , Contagem de Células , Citocinas/análise , Dinoprostona/análise , Dinoprostona/antagonistas & inibidores , Dinoprostona/farmacologia , Modelos Animais de Doenças , Camundongos , Porphyromonas gingivalis/isolamento & purificação , Fator de Necrose Tumoral alfa/antagonistas & inibidores , Fator de Necrose Tumoral alfa/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA